Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G H Gibbons

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Circulation Research|May 29, 2000
Death receptors, intimal disease, and gene therapy: are therapies that modify cell fate moving too Fas?G H Gibbons, M J Pollman
Current Opinion in Cardiology|September 1, 1994
New insights on renovascular hypertensionA O Ma, G H Gibbons
The American Journal of Cardiology|October 5, 1988
Cell biology of vascular hypertrophy in systemic hypertensionV J Dzau, G H Gibbons
Hypertension (Dallas, Tex. : 1979)|November 1, 1991
Endothelium and growth factors in vascular remodeling of hypertensionV J Dzau, G H Gibbons
The New England Journal of Medicine|May 19, 1994
The emerging concept of vascular remodelingG H Gibbons, V J Dzau
The American Journal of Cardiology|December 14, 1987
Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertensionV J Dzau, G H Gibbons
Science (New York, N.Y.)|May 3, 1996
Molecular therapies for vascular diseasesG H Gibbons, V J Dzau
Journal of Cardiovascular Pharmacology|January 1, 1993
Vascular remodeling: mechanisms and implicationsV J Dzau, G H Gibbons
Cardiovascular Drugs and Therapy|February 1, 1990
Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertensionG H Gibbons, V J Dzau
Circulation|April 20, 1999
Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cellsM J Pollman, L Naumovski, G H Gibbons
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Circulation Research|May 29, 2000
Death receptors, intimal disease, and gene therapy: are therapies that modify cell fate moving too Fas?G H Gibbons, M J Pollman
Current Opinion in Cardiology|September 1, 1994
New insights on renovascular hypertensionA O Ma, G H Gibbons
The American Journal of Cardiology|October 5, 1988
Cell biology of vascular hypertrophy in systemic hypertensionV J Dzau, G H Gibbons
Hypertension (Dallas, Tex. : 1979)|November 1, 1991
Endothelium and growth factors in vascular remodeling of hypertensionV J Dzau, G H Gibbons
The New England Journal of Medicine|May 19, 1994
The emerging concept of vascular remodelingG H Gibbons, V J Dzau
The American Journal of Cardiology|December 14, 1987
Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertensionV J Dzau, G H Gibbons
Science (New York, N.Y.)|May 3, 1996
Molecular therapies for vascular diseasesG H Gibbons, V J Dzau
Journal of Cardiovascular Pharmacology|January 1, 1993
Vascular remodeling: mechanisms and implicationsV J Dzau, G H Gibbons
Cardiovascular Drugs and Therapy|February 1, 1990
Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertensionG H Gibbons, V J Dzau
Circulation|April 20, 1999
Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cellsM J Pollman, L Naumovski, G H Gibbons
Pageof 8